cytarabine and Rhabdomyosarcoma 2

cytarabine has been researched along with Rhabdomyosarcoma 2 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Axtell, R; Beuschel, NL; Cherba, DM; Davidson, PJ; Dylewski, D; Eugster, E; Junewick, JJ; Lester, EP; Mitchell, D; Monks, NR; Monsma, DJ; Rangarajan, S; Richardson, PJ; Scott, SB; Vance, S; Webb, CP1

Other Studies

1 other study(ies) available for cytarabine and Rhabdomyosarcoma 2

ArticleYear
Using a rhabdomyosarcoma patient-derived xenograft to examine precision medicine approaches and model acquired resistance.
    Pediatric blood & cancer, 2014, Volume: 61, Issue:9

    Topics: Adult; Algorithms; Animals; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cytarabine; Drug Resistance, Neoplasm; Female; Gene Expression Profiling; Humans; Mice; Mice, Nude; Neoplasm Recurrence, Local; Oligonucleotide Array Sequence Analysis; Phenylurea Compounds; Precision Medicine; Pyrimidines; Rhabdomyosarcoma, Alveolar; Xenograft Model Antitumor Assays

2014